CDC Website CDC Website

To Join the NPIN community or

Home » Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)

To encourage multidisciplinary teams to characterize mechanisms that impact resistance to HIV broadly neutralizing antibodies (bNAbs) and develop strategies to prevent and overcome HIV resistance to bNAbs.

Application Due Date
7/30/21
Project Start Date
3/1/22
Application Contact
Alycia
Champagne
Grants Management Contact
240-669-2075
alycia.champagne@nih.gov
Technical Contact
Stephen
Smiley, PhD
Scientific/Research Contact
stephen.smiley@nih.gov
240-627-3071
Fund Duration
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Subjects
Audiences

Fund Number: 

357000

Fund ID: 

RFA-AI-21-009

Last modified: 

3/31/21